Breaking News

India’s leader promises trade and investment in a visit to Trinidad and Tobago

PORT-OF-SPAIN, TRINIDAD AND TOBAGO – In a significant diplomatic gesture reaffirming deep historical and cultural bonds, Indian Prime Minister Narendra Modi concluded a landmark two-day official visit to Trinidad and Tobago from July 3rd to July 4th, 2025. This was the first bilateral visit by an Indian prime minister to the twin-island Caribbean nation in 26 years, underscoring India's renewed commitment to strengthening ties with the Global South and, particularly, the Caribbean region. The visit, extended at the invitation of Trinidad and Tobago's Prime Minister Kamla Persad-Bissessar, was imbued with profound significance, coinciding with the 180th anniversary of the arrival of Indian immigrants to Trinidad and Tobago in 1845. The warm reception and the conferment of the Order of the Republic of Trinidad and Tobago, the country's highest national honour, upon Prime Minister Modi, highlighted the...
Continue reading
India’s Nazara acquires 48% stake in PokerBaazi operator Moonshine Technology
Science & Technology

India’s Nazara acquires 48% stake in PokerBaazi operator Moonshine Technology

Technology tamfitronics India-based gaming and sports media company Nazara Technologies has acquired a 47.7% stake in Moonshine Technology Private, operator of the PokerBaazi online poker platform.As part of the deal, Nazara will pay ₹832 Crore (£75.4m/€89.3m/$99.2m) to purchase the stake. Nazara will also inject ₹150 Crore in primary capital into PokerBaazi operator Moonshine via compulsory convertible preference shares. This stock will automatically convert into equity shares once the deal is completed. The flagship PokerBaazi brand has approximately 340,000 monthly active users and draws 85% of the company’s net revenue. Moonshine also operates the SportsBaazi fantasy sports platform, which generates 12% of overall revenue.Moonshine is headed by founder and CEO Navkiran Singh, with support from co-founders Puneet Singh, Varun Ganjoo, Avneet Rana, and Anirudh Chaudhry.“As the Indian gaming sector continues to grow, we firmly believe that...
Continue reading
World Bank pegs India’s growth at 7% in FY25
Business News

World Bank pegs India’s growth at 7% in FY25

Business new tamfitronics New Delhi: The World Bank has forecast India’s GDP growth at 7% for 2024-25, despite a subdued external environment and the dissipation of post-pandemic rebound effects. This is an upgrade from the 6.6% estimated earlier and the multilateral agency joins other agencies in raising India’s growth forecast after a strong 8.2% growth in the previous year.The India Development Update report said external risks to the outlook are significant.In particular, geopolitical tensions could put pressure on commodity prices and critical supply chains and resurgent inflation could still keep global interest rates“higher for longer.” “These risks notwithstanding, medium-term prospects are positive. The significant expansion of public investment in recent years should crowd in corporate investments and a recovery of agriculture and declining inflation should boost private consumption growth. Under this baseline scenario, robust...
Continue reading
India’s Bharat Biotech plans global launch for its oral cholera vaccine Hillchol
Science & Technology

India’s Bharat Biotech plans global launch for its oral cholera vaccine Hillchol

Technology tamfitronics Technology tamfitronics Story highlightsA report by the news agency Reuters said that Bharat Biotech's Hillchol would compete with South Korea's EuBiologics Co, which is the only WHO-approved producer of cholera vaccines.Indian biotechnology giant Bharat Biotech said on Tuesday (Aug 27) that its oral cholera vaccine Hillchol cleared a late-stage trial. Bharat Biotech said that India's drug regulator approved the vaccine, adding, it was now planning for a global launch.The company said it would apply for the World Health Organization's (WHO) pre-qualification to supply to major buyers like the UNICEF. A report by the news agency Reuters said that Hillchol would compete with South Korea's EuBiologics Co, which is the only WHO-approved producer of cholera vaccines.Technology tamfitronics A look at Bharat Biotech's plan for HillcholSpeaking to Reuters, Bharat Biotech said that its first intention was to help...
Continue reading